with

XPPen Partners with Annecy International Animation Film Festival to Launch the Inaugural XPPen Award for Graduation Films, Nurturing the Next-Gen Talent

LOS ANGELES, June 16, 2025 /PRNewswire/ -- XPPen, the leading digital art innovation brand, is thrilled to announce its partnership…

6 months ago

Vijay Dhawangale Honoured with Excellence in Healthcare Award at UK-India Health Partnership Awards 2025

LONDON, June 16, 2025 /PRNewswire/ -- In a landmark celebration of cross-border healthcare excellence, Vijay Dhawangale, Founder of Lifenity Group, was…

6 months ago

Kia Tasman Blazes New Trail for Pickup Truck Segment with Exceptional OffRoad Ability

Kia’s first pickup truck is built to tackle both on- and off-road challengesRobust platform, confident wading capability and durable cargo…

6 months ago

Kia EV4 redefines the electric sedan experience with classleading innovation, spacious interior and premium technology

Kia reveals full technical details of the EV4, the brand’s first electric compact sedanBold, innovative design and advanced technology bring…

6 months ago

ECLT10 Season 3 Auction Shatters Records with Historic Bids and Power-Packed Rosters

NEW DELHI, June 16, 2025 /PRNewswire/ -- The ECLT10 Season 3 Auction, lived up to the hype and beyond as…

6 months ago

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever…

6 months ago

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

6 months ago

Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…

6 months ago

CGTN: Second China-Central Asia Summit eyes a closer China-Central Asia community with a shared future

BEIJING, June 14, 2025 /PRNewswire/ -- Following the announcement by China's Foreign Ministry that President Xi Jinping will attend the second…

6 months ago

FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR’S AWARDEES AT CONI

ROME, June 11, 2025 /PRNewswire/ -- The sense of anticipation is increasing, the names are unveiled, and the stories begin…

6 months ago